Active Ingredient(s):Doxapram FDA Approved: * June 23, 1965 Pharm Company: *BAXTER HLTHCARE Category:Respiratory Failure
Doxapram hydrochloride (marketed as Dopram, Stimulex or Respiram) is a respiratory stimulant. Administered intravenously, doxapram stimulates an increase in tidal volume, and respiratory rate.
1 Mechanism of action
4 Side effects
5 See also
Mechanism of action
A vial of doxapram
Doxapram stimulates chemoreceptors in the carotid bodies of the carotid arteries, which in turn, stimulates the respiratory centre in the brain stem.
* May have multiple approval dates, manufacturers, or labelers.